CJEU rules on royalties for unpatented technology
Richard Binns and Nicola Walles consider the impact of the Court of Justice of the EU’s recent ruling on the payment of royalties for unpatented technology
In 1992, Genentech entered into a German law governed licence agreement under which it took a non-exclusive, worldwide licence for a patent that covered the use of a human cytomegalovirus enhancer (HMCV enhancer). Originally owned by Behringwerke, the patent was...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.